The hard part was never identifying the opportunity. It was getting it acted upon.
PGxAlly closes the gap through a pharmacist-led execution model that combines clinical expertise, workflow technology, laboratory partnerships, and provider engagement, turning medication insights into completed actions and measurable outcomes for health plans, PBMs, employers, and health systems.
Close medication gaps at scale and prove the outcomes.
Close gaps at scale →Grow clinical revenue and services beyond dispensing.
Grow your pharmacy →Better medication decisions with less work for your team.
Lighten the load →Reduce healthcare costs and improve employee health.
Lower plan costs →Plans, PBMs, and providers can already identify adherence, polypharmacy, deprescribing, behavioral-health, specialty, and PGx opportunities at scale. What's missing is action. Identified opportunities that never get executed cost money to produce and return nothing.
Most organizations already have analytics, quality programs, pharmacists, and care teams. The challenge is converting thousands of identified opportunities into completed actions, without adding significant operational overhead. PGxAlly is the execution layer between identification and outcome.
We're an enhancer, not a replacement. PGxAlly plugs into what you already have and closes the gap between opportunity and action.
PGxAlly began with a simple observation: medication decisions drive a significant share of healthcare outcomes and costs, yet most opportunities to improve those decisions never reach action.
We started in pharmacogenomics, helping providers personalize medication therapy to a patient's genetics. What we learned was bigger than PGx: the hard part was never identifying the opportunity. It was getting it acted upon.
So we built the layer that closes that gap. Today, PGxAlly combines pharmacists, technology, laboratory partnerships, and workflow integration to help healthcare organizations close medication-related gaps at scale. Precision medicine is one of six clinical modules today, and the place our story began.
Where we started. Genetics-guided medication therapy.
Identifying opportunities was never the hard part. Execution was.
Pharmacists + technology that turn medication insight into completed action.
The same promise on every engagement: do the clinical work, route it through the right workflow, and close the loop with proof.
Outreach, recommendation prep, documentation, and follow-up, so providers and members say yes. You don't add headcount. We bring the clinicians.
Technology and PGx route the right recommendation to the right person at the right moment, inside existing clinical workflow, with closed-loop tracking.
We don't stop at insight. We complete the action and return the result: gap-closure rates, estimated savings where data is available, and quality lift.
One platform, six clinical interventions. PGx is one module among them, not the whole story.
Close the gap between prescribed and taken.
Make the handoff safe, and keep people home.
Less medication burden, fewer adverse events.
Optimize therapy for mental-health conditions.
Appropriate use and better value from specialty meds.
Use genetic insight for safer, more effective choices.
Members are automatically routed to the right pharmacist-led intervention based on their medications, conditions, and care gaps.
Bring us the opportunities you already identify, or we surface them with you.
Assess, engage, optimize, recommend, document, and close. Done by our clinicians.
The recommendation arrives in workflow and the action actually gets completed.
Results are tracked and reported back to the plan: gap closure, savings, quality.
Two examples of how an identified opportunity becomes a completed, tracked action.
Depending on the program, the outcomes we measure include:
We're currently partnering with organizations to establish baseline metrics and demonstrate measurable outcomes. Every engagement is structured around transparent reporting and continuous improvement.
Every health plan, PBM, and system already has analytics, dashboards, and recommendations. What almost none of them have is the pharmacist network to execute on all of it, at scale and on demand.
Everyone has it.
Everyone has them.
Everyone generates them.
Almost no one has this. It's the layer that turns opportunities into completed actions, and it's what PGxAlly is.
PGxAlly provides the pharmacist layer that turns medication opportunities into completed actions. We bring all the labs, the technology, and the clinicians to do the work, so your team doesn't have to grow to deliver more.
The category is crowded with tools that stop at insight. We're a different thing.
Most partners begin with one focused initiative, then expand into what works.
Most partners begin with a focused clinical initiative, adherence, polypharmacy, PGx, behavioral health, or transitions of care. Together we define success, measure outcomes, and determine where expansion makes sense.
No enterprise-wide transformation required. We plug into your existing workflow and prove value on a contained program first.
We'll show you how we close them, and what that's worth at your next renewal.